Saturday, January 23, 2010

Coleman wins big in 3rd District GOP straw poll

With nearly the entire population of Arkansas announcing their candidacy to run against Blanche Lincoln in November, surpising things are going to happen.

According to Curtis Coleman's campaign, today in the only Republican stronghold in the state of Arkansas Coleman won a resounding victory against all opponents. Taking 43% of the 101 votes in the 3rd District Republican straw poll, he received more than twice the votes of his nearest opponent State Senator Gilbert Baker who took 20%.

The following is a press release from the Coleman campaign:

( FAYETTEVILLE , AR – 23 JAN 2010 Conservative Republican U.S. Senate candidate Curtis Coleman was awarded a victory by grassroots workers and party activists at the 3rd Congressional District’s Republican Straw Poll.

Coleman received 43 percent of the 101 votes cast, followed by state Senator Gilbert Baker, 20 percent; and Randy Alexander, 9 percent.

“I am honored by the confidence expressed in me by these leaders of the Republican Party of Arkansas,” Coleman said. “I will not waver, I will not quit and I will not let you down in this fight to protect our fundamentals of freedom.”

Eight of the nine candidates attended the two-day events in Fayetteville , Ark. and participated in a candidate’s forum.

Curtis Coleman is Cofounder and former President and Chief Executive Officer of Safe Foods Corporation. Founded in January 1999, the Arkansas company is helping make food safer on four continents. Coleman stepped aside from his position as CEO of Safe Foods in September 2009 to focus 100% of his time on his campaign to represent Arkansas in the U.S. Senate seat currently occupied by Sen. Blanche Lincoln (D).

*LCRC does not endorse any candidate until after the primary election. This post is for informational purposes only and in no way constitutes an endorsement by the LCRC. LCRC will post press releases from any Republican candidate who submits them to email:webmaster@lonokegop.com .

No comments:

Post a Comment